Bristol Myers Squibb Stock Alpha and Beta Analysis

BMY Stock  USD 53.90  2.07  3.70%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bristol Myers Squibb. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bristol Myers over a specified time horizon. Remember, high Bristol Myers' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bristol Myers' market risk premium analysis include:
Beta
(0.06)
Alpha
0.019
Risk
1.46
Sharpe Ratio
(0.04)
Expected Return
(0.06)
Please note that although Bristol Myers alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Bristol Myers did 0.02  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Bristol Myers Squibb stock's relative risk over its benchmark. Bristol Myers Squibb has a beta of 0.06  . As returns on the market increase, returns on owning Bristol Myers are expected to decrease at a much lower rate. During the bear market, Bristol Myers is likely to outperform the market. At this time, Bristol Myers' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 12.19 in 2025, whereas Book Value Per Share is likely to drop 5.62 in 2025.

Bristol Myers Quarterly Cash And Equivalents

7.51 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Bristol Myers Backtesting, Bristol Myers Valuation, Bristol Myers Correlation, Bristol Myers Hype Analysis, Bristol Myers Volatility, Bristol Myers History and analyze Bristol Myers Performance.

Bristol Myers Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bristol Myers market risk premium is the additional return an investor will receive from holding Bristol Myers long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bristol Myers. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bristol Myers' performance over market.
α0.02   β-0.06

Bristol Myers expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bristol Myers' Buy-and-hold return. Our buy-and-hold chart shows how Bristol Myers performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Bristol Myers Market Price Analysis

Market price analysis indicators help investors to evaluate how Bristol Myers stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bristol Myers shares will generate the highest return on investment. By understating and applying Bristol Myers stock market price indicators, traders can identify Bristol Myers position entry and exit signals to maximize returns.

Bristol Myers Return and Market Media

The median price of Bristol Myers for the period between Mon, Nov 18, 2024 and Sun, Feb 16, 2025 is 57.13 with a coefficient of variation of 2.58. The daily time series for the period is distributed with a sample standard deviation of 1.48, arithmetic mean of 57.22, and mean deviation of 1.21. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
More than 1,200 Bristol council houses may be sold in fire sale
01/13/2025
2
Bristol Myers Squibb Foundation, Texas Childrens Global HOPE, Baylor College of Medicine Global Health Launch Program to Combat Sickle Cell Disease in Sub-Sahar...
01/17/2025
3
Disposition of 2543 shares by Greg Meyers of Bristol Myers subject to Rule 16b-3
01/31/2025
 
Bristol Myers dividend paid on 3rd of February 2025
02/03/2025
4
Bristol-Myers Squibb Q4 2024 Earnings Preview Strong product sales to continue into 2025
02/05/2025
5
Stone Summit Wealth LLC Sells 520 Shares of Bristol-Myers Squibb
02/10/2025
6
Covid inquiry wants to ensure Bristol citizens are heard
02/11/2025
7
Bristol-Myers Squibb Company Jim Cramer No, No, You Dont Hold
02/12/2025
8
Im not normal anymore Hair stylist sues companies over link between hair dye and cancer
02/13/2025
9
Kahn Brothers Reduces Stake in Citigroup Inc by 23.58
02/14/2025

About Bristol Myers Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bristol or other stocks. Alpha measures the amount that position in Bristol Myers Squibb has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 2025 (projected)
Dividend Yield0.03020.04470.04240.0274
Price To Sales Ratio3.322.362.372.95

Bristol Myers Upcoming Company Events

As portrayed in its financial statements, the presentation of Bristol Myers' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bristol Myers' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Bristol Myers' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Bristol Myers. Please utilize our Beneish M Score to check the likelihood of Bristol Myers' management manipulating its earnings.
2nd of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Bristol Myers

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.